JP2024532807A5 - - Google Patents
Info
- Publication number
- JP2024532807A5 JP2024532807A5 JP2024508768A JP2024508768A JP2024532807A5 JP 2024532807 A5 JP2024532807 A5 JP 2024532807A5 JP 2024508768 A JP2024508768 A JP 2024508768A JP 2024508768 A JP2024508768 A JP 2024508768A JP 2024532807 A5 JP2024532807 A5 JP 2024532807A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- deuterium concentration
- agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/112521 | 2021-08-13 | ||
| CN2021112521 | 2021-08-13 | ||
| CN2022106648 | 2022-07-20 | ||
| CNPCT/CN2022/106648 | 2022-07-20 | ||
| PCT/CN2022/111089 WO2023016440A1 (en) | 2021-08-13 | 2022-08-09 | Deuterated compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532807A JP2024532807A (ja) | 2024-09-10 |
| JP2024532807A5 true JP2024532807A5 (https=) | 2026-02-27 |
Family
ID=85199822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508768A Pending JP2024532807A (ja) | 2021-08-13 | 2022-08-09 | 重水素化化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240270731A1 (https=) |
| EP (1) | EP4384507A4 (https=) |
| JP (1) | JP2024532807A (https=) |
| KR (1) | KR20240047401A (https=) |
| CN (1) | CN116848095B (https=) |
| AR (1) | AR126778A1 (https=) |
| CA (1) | CA3227149A1 (https=) |
| IL (1) | IL310176A (https=) |
| MX (1) | MX2024001889A (https=) |
| TW (1) | TW202320762A (https=) |
| WO (1) | WO2023016440A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118480034B (zh) * | 2023-02-13 | 2025-02-11 | 礼邦医药(香港)有限公司 | 氘代化合物的晶型或盐 |
| TW202547458A (zh) * | 2024-03-26 | 2025-12-16 | 香港商禮邦醫藥（香港）有限公司 | 用於治療體染色體顯性多囊性腎病之方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60211891T2 (de) * | 2001-05-15 | 2007-05-24 | F. Hoffmann-La Roche Ag | Carbonsäure-substituierte oxazol-derivate zur verwendung als ppar-alpha und -gamma aktivatoren zur behandlung von diabetes |
| US7262303B2 (en) * | 2003-09-29 | 2007-08-28 | Hoffman-La Roche Inc. | Process for the production of chiral propionic acid derivatives |
| JP7618384B2 (ja) * | 2017-02-21 | 2025-01-21 | ジェンフィ | Ｐｐａｒアゴニストとｆｘｒアゴニストとの組合せ |
| CN109265380A (zh) * | 2017-10-18 | 2019-01-25 | 深圳市塔吉瑞生物医药有限公司 | 取代的丙-2-烯-1-酮化合物及其药物组合物 |
| WO2020156683A1 (en) * | 2019-02-01 | 2020-08-06 | F. Hoffmann-La Roche Ag | Aleglitazar for use in the treatment or prevention of major adverse cardiac events |
| CN112209896B (zh) * | 2019-07-10 | 2023-05-16 | 苏州泽璟生物制药股份有限公司 | 噻唑烷二酮衍生物以及包含其的药物组合物 |
| CN118480034B (zh) * | 2023-02-13 | 2025-02-11 | 礼邦医药(香港)有限公司 | 氘代化合物的晶型或盐 |
-
2022
- 2022-08-09 TW TW111129796A patent/TW202320762A/zh unknown
- 2022-08-09 JP JP2024508768A patent/JP2024532807A/ja active Pending
- 2022-08-09 EP EP22855421.8A patent/EP4384507A4/en active Pending
- 2022-08-09 CA CA3227149A patent/CA3227149A1/en active Pending
- 2022-08-09 CN CN202280014488.6A patent/CN116848095B/zh active Active
- 2022-08-09 US US18/293,337 patent/US20240270731A1/en active Pending
- 2022-08-09 MX MX2024001889A patent/MX2024001889A/es unknown
- 2022-08-09 IL IL310176A patent/IL310176A/en unknown
- 2022-08-09 WO PCT/CN2022/111089 patent/WO2023016440A1/en not_active Ceased
- 2022-08-09 KR KR1020247007871A patent/KR20240047401A/ko active Pending
- 2022-08-12 AR ARP220102177A patent/AR126778A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024532807A5 (https=) | ||
| JP2024050527A5 (https=) | ||
| JP2011500659A5 (https=) | ||
| JP2007508360A5 (https=) | ||
| CA2607848A1 (en) | 3-substituted (3-phenyl)-propionic acid derivatives for the treatment of metabolic disorders | |
| JP2007525516A5 (https=) | ||
| JP2007530698A5 (https=) | ||
| JP2022519744A5 (https=) | ||
| JP2010523476A5 (https=) | ||
| JP2010502730A5 (https=) | ||
| RU2009103675A (ru) | Производные бензимидазола в лечении расстройств, ассоциированных с ванилоидным рецептором trpv1 | |
| JP2021530513A5 (https=) | ||
| JP2007522135A5 (https=) | ||
| JP2024516826A5 (https=) | ||
| JP2025500826A5 (https=) | ||
| JP2023516714A (ja) | 新規ｅｐ４拮抗薬の合成及びその癌及び炎症における使用 | |
| JP2010506919A5 (https=) | ||
| JP2006524252A5 (https=) | ||
| JP2020111571A5 (https=) | ||
| JP2023510865A5 (https=) | ||
| CA2559530A1 (en) | Novel benzyl(idene)-lactam derivatives | |
| JP2023519289A5 (https=) | ||
| JP2013507327A5 (https=) | ||
| JP2018535226A5 (https=) | ||
| KR20130119927A (ko) | 이미다졸 유도체, 그의 제조 방법 및 용도 |